This model is thought to recapitulate the sequence of events seen in AITL patients, in which Tet2 was invalidated in all HSCs and lineages derived thereof, while RhoAG17V was only detected in the mature T cells45,131. This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.